johnson & johnson

Business News, Market News, News, Stocks

China Sees Worst Covid Outbreak Yet, Vaccine Makers Stocks Surge

By Ibukun Ogundare Mar 15, 2022

As the global health crisis persists, vaccine makers are looking forward to huge revenues this year.

Business News, News

Johnson & Johnson Announces Plans to Split Its Business Unit within 24 Months

By Godfrey Benjamin Nov 12, 2021

The proposed split of the company’s business units has been listed as an avenue to drive effective resource allocations and management across the board.

Business News, Market News, News, Stocks

S&P 500 Closes at Its ATH with Growth Fueled by Positive Earnings Report

By Godfrey Benjamin Oct 20, 2021

The move by the major American stock market indices including the S&P 500 to hit their new ATHs may be fast-tracked by increased earnings reports from the companies that are going to unveil their results for the previous quarter.

Business News, Market News, News, Wall Street

Johnson & Johnson COVID Vaccine Sales Figures Hit $502M, Boosting J&J Q3 2021 Earnings Report

By Tolu Ajiboye Oct 19, 2021

The boost from the COVID vaccine sales, among other factors, has pushed Johnson & Johnson to increase its full-year earnings guidance.

Business News, Indices, Market News, News, Stocks

Wall Street Extends Rally with S&P 500 and Nasdaq Gaining for 5th Consecutive Day

By Bhushan Akolkar Aug 26, 2021

The markets remained pumped up ahead of the Fed meeting on Thursday, where the central bank will discuss any stimulus tapering measures.

Business News, Indices, Market News, News, Stocks

Wall Street Keeps Up with Upward Momentum for Second Consecutive Day, Dow Jones Up 280 Points

By Bhushan Akolkar Jul 22, 2021

Dow Jones recovers all losses from Monday with two-day consecutive rallies. Interestingly, the bond market is also fuelling optimism on Wall Street.

Business News, Editor's Choice, Market News, News, Stocks

JNJ Stock Up Over 2.5% Today, Johnson & Johnson Reports Profitable Q1 Earnings Results

By Steve Muchoki Apr 20, 2021

During the first three months of 2021, Johnson & Johnson reported revenue of $22.32 billion versus $21.98 billion expected by analysts.

Business News, Market News, News, Stocks

Nasdaq Composite Leads Market Gains as Stocks Remain Unmoved with JNJ Vaccine Halt

By Godfrey Benjamin Apr 14, 2021

While the announcement negatively impacted JNJ shares, the overall outlook in tech stocks was bullish.

Business News, Indices, Market News, News, Stocks

US Stock Market Records Massive Pull Back Following Stunning Start of Week

By Godfrey Benjamin Mar 3, 2021

The US stock market is perhaps responding to a 1.41% drop in the 10-Year Treasury rate, a major focus point for equity investors.

Business News, Market News, News, Stocks, Wall Street

JNJ Stock Up 3% in Pre-market as FDA Approves Johnson & Johnson Single-shot COVID-19 Vaccine

By Godfrey Benjamin Mar 1, 2021

The vaccine developed by Johnson & Johnson has varying efficacies as shown by FDA documents. In the United States, efficiency is at 72%, 66% in Latin America, and about 64% in South Africa.

Business News, Market News, News, Stocks, Wall Street

JNJ Stock Down 0.1%, J&J Says We May Need Annual Coronavirus Vaccination

By Steve Muchoki Feb 10, 2021

J&J stock is set to significantly benefit if the United States FDA approves the company’s coronavirus vaccine for emergency use. 

Business News, Market News, News, Stocks, Wall Street

AstraZeneca Vaccine Appears Less Effective against COVID-19 in South Africa

By Ibukun Ogundare Feb 8, 2021

At press time, AstraZeneca stock is at $50 in the pre-market trading, which shows a 0.54% increase over its previous close of $49.73.